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RibonucleoproteinThe negative sense RNA genome of inﬂuenza A virus is transcribed and replicated in the nuclei of infected
cells by the viral RNA polymerase. Only four viral polypeptides are required but multiple cellular components
are potentially involved. We used ﬂuorescence recovery after photobleaching (FRAP) to characterise the
dynamics of GFP-tagged viral ribonucleoprotein (RNP) components in living cells. The nucleoprotein (NP)
displayed very slow mobility that signiﬁcantly increased on formation of transcriptionally active RNPs.
Conversely, single or dimeric polymerase subunits showed fast nuclear dynamics that decreased upon
formation of heterotrimers, suggesting increased interaction of the full polymerase complex with a relatively
immobile cellular component(s). Treatment with inhibitors of cellular transcription indicated that in part,
this reﬂected an interaction with cellular RNA polymerase II. Analysis of mutated inﬂuenza virus polymerase
complexes further suggested that this was through an interaction between PB2 and RNA Pol II separate from
PB2 cap-binding activity. © 2009 Elsevier Inc. Open access under CC BY license.Introduction
Inﬂuenza A virus ribonucleoprotein (RNP) particles contain all the
viral components essential and sufﬁcient for transcription and
replication of the viral genome: one copy of the heterotrimeric
RNA-dependent RNA polymerase formed by PA, PB1 and PB2 (3P),
and the genomic vRNA wrapped around oligomerised nucleoprotein
(NP) (Huang et al., 1990; Portela and Digard, 2002). Viral RNA
synthesis occurs in the nucleus of infected cells (Herz et al., 1981;
Jackson et al., 1982), where the viral polymerase transcribes the vRNA
segments to generate mRNAs and also replicates the vRNAs via a
complementary positive sense cRNA intermediate. Multiple host
nuclear functions are parasitized during these processes, requiring an
extensive interplay between viral and host components that is far
from fully understood. Viral mRNA synthesis depends on RNA
polymerase II (Pol II) to supply mRNA cap structures that are recycled
from cellular pre-mRNAs as primers for viral transcription (Elton et
al., 2006). It also requires Pol II activity for nuclear export of a subset of
viral messages (Amorim et al., 2007; Vogel et al., 1994; Wang et al.,
2008), as well as the splicing apparatus for processing of two viral
mRNAs (Elton et al., 2006). Consistent with this, the 3P viral
polymerase complex interacts with the large subunit of Pol II
(Engelhardt et al., 2005; Mayer et al., 2007; Rameix-Welti et al.,
2009) although whether this is to the beneﬁt of the virus and/or the.
 license.detriment of Pol II function remains to be determined (Chan et al.,
2006; Rodriguez et al., 2007). A variety of other host derived nuclear
interaction partners of the viral RNP components have also been
deﬁned (Amorim and Digard, 2006; Engelhardt and Fodor, 2006;
Josset et al., 2008). Some of these cellular proteins are postulated to
have accessory or inhibitory functions in trafﬁcking of RNP and RNP
components, viral transcription, and genome replication, but in many
cases, the interaction is of unknown functional signiﬁcance.
To further understand the interplay between inﬂuenza virus and
the host cell we analysed the dynamic properties of viral RNP
components in their authentic nuclear environment. Fluorescent
Recovery After Photobleaching (FRAP) experiments were carried out
on live-cells expressing recombinant green ﬂuorescent protein (GFP)-
tagged viral proteins. We ﬁnd that the intranuclear dynamics of the
inﬂuenza A virus RNA synthesis machinery is strongly inﬂuenced by
the assembly state of its sub-components and the activity of host Pol II.
Results
Nuclear dynamics of recombinant inﬂuenza RNPs and their components
To investigate the dynamics of viral RNP components in FRAP
experiments, plasmids expressing C-terminally GFP-tagged polymer-
ase proteins (Fodor and Smith, 2004) or an N-terminally GFP-tagged
NP molecule were employed and the system for recreating recombi-
nant RNPs validated. First, we analysed the localisation of GFP-tagged
polymerase subunits on their own or in dimer (2P) or trimer (3P)
155E.M. Loucaides et al. / Virology 394 (2009) 154–163combinations with the other untagged P subunits in living 293T cells.
All GFP-tagged subunits expressed in the full polymerase (3P) context
localised to the nucleus (Fig. 1A). Individually expressed PB2-GFP also
accumulated in the nucleus while PA-GFP and PB1-GFP were only
efﬁciently imported in the presence of the other (Fig. 1A). This
conﬁrms data previously obtained on ﬁxed cells indicating that PA
and PB1 undergo nuclear import as a dimer (Fodor and Smith, 2004).
GFP-NP also localised efﬁciently to the nucleus whether expressed
alone or with a model vRNA and/or 3P (Fig. 1A, lower panels). Next,
cells were multiply transfected with plasmids expressing a model
cRNA segment containing a chloramphenicol acetyl-transferase (CAT)
gene and various combinations of tagged and untagged polymerase
and NP proteins to recreate functional RNPs (Fodor et al., 2002; HuangFig. 1. Reconstitution of recombinant GFP-tagged inﬂuenza RNPs in 293T cells. (A) Living
polymerase protein pairs, as labelled, 3P; the full polymerase complex) were analysed direct
with plasmids expressing a synthetic vRNA encoding CAT and three (2P-GFP) or four of the
Three days post-transfection cells were analysed for CAT accumulation by ELISA. The mean an
by WT RNPs. (C, D) Cells were transfected with plasmids expressing the indicated polypept
along with NP and either a cRNA or vRNA containing a CAT gene respectively) or left untransf
a marker) were analysed by SDS-PAGE and western blotting with antisera against PA, PB1,
radiolabelled oligonucleotides speciﬁc for negative (top panel) or positive sense (lower pane
autoradiography. Primer extension products resulting from the indicated CAT RNA specieset al., 1990; Mullin et al., 2004). Consistent with a previous study
(Fodor and Smith, 2004), analysis of CAT accumulation conﬁrmed the
transcriptional competence of the derivatised P and NP proteins.
Replacement of any single RNP polypeptide with its GFP-tagged
counterpart resulted in between ~25% and 95% of the activity seen
with an untagged RNP, and in all cases activity was several hundred
fold higher than the background obtained in the absence of PB1 (Fig.
1B). Cell lysates were also analysed by SDS-PAGE and Western
blotting. All three polymerase subunits were detected in similar
quantities whether in the 3P or RNP context, while NP was present in
RNP-transfected samples (Fig. 1C, lanes 3–7, 10). Anti-GFP detected
both GFP and PB2-GFP at the expected sizes with no obvious GFP-
containing degradation products in the latter (Fig. 1B, lanes 3 and 4–cells expressing GFP-tagged RNP subunits alone or in combinations as indicated (2P;
ly for GFP expression by confocal microscopy. Scale bar 5 μm. (B) Cells were transfected
RNP polypeptides, either all untagged (WT) or with the indicated one tagged with GFP.
d range from two independent experiments is plotted relative to the amount produced
ides (P, PB2-GFP; 3P, PB2-GFP, PA and PB1; cRNP and vRNP, PB2-GFP, PA and PB1 SDD
ected (−). 24 h post-transfection (C) cell lysates and samples of puriﬁed virus (lane 1, as
PB2, NP and GFP; (D) total RNA was extracted and analysed by primer extension using
l) CAT transcripts. Radiolabelled products were separated by urea-PAGE and detected by
are labelled.
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subunit alone and in combination with other viral proteins. Similarly,
analysis of GFP-NP transfected samples conﬁrmed expression of a
polypeptide of the expected size that reacted with both anti-NP and
anti-GFP with no obvious degradation products (Fig. 1C, lanes 8–10).
The presence of viral RNAs in transfected cells was veriﬁed using
reverse transcription primer extension analysis. In cells transfected
with the viral polymerase alone no viral RNA species could be
detected (Fig. 1D, lane 1). In the presence of replication competent
RNPs, vRNA as well as m- and cRNA were detected, indicating active
viral transcription and replication (Fig. 1D, lane 4). WhenWT PB1 was
substituted with a PB1-SDD active-site mutant (Vreede et al., 2004)
model vRNPs or cRNPs, according to the polarity of the reporter
segment employed, were obtained. In such samples, only RNA of the
corresponding input polarity was detected (Fig. 1D, lanes 2–3),
conﬁrming encapsidation and protection of Pol I-transcribed RNA into
transcriptionally inert RNPs (Vreede et al., 2004). Thus overall, the
recombinant system used here successfully reconstituted GFP-tagged
inﬂuenza virus RNPs.
Next, we employed FRAP to analyse the nuclear dynamics of
inﬂuenza A virus RNP components, pursuing a strategy in which RNPs
were built up incrementally, allowing comparison of the mobility of
the various sub-assemblies with the ﬁnal functional entity. Accord-
ingly, 293T cells were transfected with plasmid mixtures expressing
individual GFP-tagged polymerase subunits alone, in combination
with a second untagged polymerase subunit, or with both other
subunits to reconstitute the full heterotrimeric polymerase. PB2-GFPFig. 2. Nuclear mobility of viral polymerase proteins. 293T cells were transfected with plasm
polymerase proteins and NP as indicated. 24 h post-transfection ﬂuorescent cells were anal
each transfection combination are plotted. See Table 1 for information on the number of redisplayed very rapid recovery kinetics and fully recovered to initial
ﬂuorescence intensity indicating the virtual absence of immobile
molecules (Fig. 2A). To quantify P protein nuclear dynamics, mean
time to half recovery (t1/2) and diffusion coefﬁcient (DC) values were
calculated from the ﬂuorescence recovery data for individual cells,
utilising multiple repeat experiments. (Fig. 2C, Table 1). A degree of
cell-to-cell variability was seen among the estimates for the DC and
the half recovery time for each particular setting, but when the
distributions of individual DC values were plotted on histogramsmost
of them formed a bell-shaped distribution (Fig. 3A). This validates the
idea of a typical time for recovery for that setting and also the
approach of estimating that time by taking an average of the estimates
for each individual cell. These data conﬁrmed the fast nuclear
dynamics of PB2 alone with an average t1/2 value of around 1 s and
a DC of nearly 1 μm2/s (Fig. 2C, Table 1). Co-expression of PA did not
signiﬁcantly alter PB2-GFP dynamics (Figs. 2A, C, Table 1), consistent
with the weak interaction between PB2 and PA in the absence of PB1
(Digard et al., 1989; Hemerka et al., 2009). Expressing PB2-GFP in
combination with PB1 caused a slight reduction (less than 2-fold; Fig.
2C, Table 1) in the rate of ﬂuorescence recovery, although recovery
still reached 100% of initial ﬂuorescence intensity (Fig. 2A). However,
a highly statistically signiﬁcant (as assessed by t-test) near 10-fold
decrease in DC was observed upon expression of the full 3P complex
(Fig. 2C, Table 1). Fluorescence recovery was also incomplete,
suggesting a fraction of the inﬂuenza polymerase was now static
within the nucleus during the time span of the experiment (Fig. 2A).
When the spread of DC values from individual cells was considered,ids expressing (A) PB2-GFP alone or (B) PB1-GFP and PA in combinations with other
ysed by FRAP. The average recovery kinetics are plotted. (C, D) The mean DC±SEM for
petitions and statistical analyses.
Table 1
Nuclear dynamics of combinations of inﬂuenza proteins.
Transfected plasmids Total n
(exp)a
t1/2 (s)
(mean±s.d.)
rel. to
P/2P
p value t-test
different to bP/2P
DC (μm2/s)
(mean±s.d.)
rel. to
P/2P
p value t-test
different to bP/2P
PB2-GFP 55 (5) 0.93±0.83 1 1 0.91±0.62 1 1
PB2-GFP, PA 22 (2) 0.86±0.51 0.92 0.72 0.88±0.53 0.97 0.87
PB2-GFP, PB1 30 (3) 1.44±0.90 1.55 0.01 0.56±0.40 0.62 7.6×10−3
PB2-GFP, PB1, PA 64 (6) 7.44±5.28 8.00 9.0×10−16 0.11±0.07 0.12 3.8×10−18
PB2-GFP, PB1-SDD,PA 68 (6) 8.92±5.88 9.59 1.9×10−18 0.09±0.07 0.10 1.0×10−20
PB2-GFP, PB1, PA, NP 22 (2) 8.92±6.39 9.59 1.7×10−14 0.08±0.04 0.09 2.6×10−8
PA-GFP, PB1 20 (2) 1.05±0.81 1 1 1.13±1.18 1 1
PA-GFP, PB2 24 (2) 0.88±1.75 0.84 0.69 1.49±1.06 1.32 0.29
PA-GFP, PB1, PB2 20 (2) 2.34±1.39 2.23 9.7×10−4 0.32±0.19 0.28 4.3×10−3
PA-GFP, PB1-SDD, PB2 24 (2) 2.49±1.69 2.37 1.2×10−3 0.31±0.20 0.27 1.6×10−3
PB1-GFP, PA 31 (3) 1.17±0.85 1 1 0.87±0.82 1 1
PB1-GFP, PA, PB2 32 (3) 6.02±4.20 5.14 3.5×10−8 0.13±0.10 0.15 5.2×10−6
PB1-GFP, PA, PB2-F363A 33 (3) 1.53±0.91 1.31 0.1 0.49±0.31 0.56 0.02
PB1-GFP, PA, PB2-F404A 34 (3) 5.97±3.48 5.10 3.1×10−10 0.12±0.08 0.14 1.9×10−6
a Total number of cells analysed from (in parentheses) the indicated number of independent transfections.
b P indicates PB2-GFP; 2P, PB1-GFP+PA or PB1+PA-GFP as appropriate.
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showed only minimal overlap with the values obtained from cells
expressing only PB2-GFP (Fig. 3B). Thus although the FRAP technique
does not distinguish between ‘free’ PB2-GFP molecules and PB2-GFP
incorporated into a 3P complex in any one cell, the distinctly different
distributions of DCs from single cells expressing either PB2-GFP alone
or in the 3P context suggests that the majority of the latter cells
contained a signiﬁcant population of PB2-GFP in the form of the
polymerase complex. Reliable data concerning the nuclear mobility of
either PA-GFP or PB1-GFP expressed alone could not be generated
because of their inefﬁcient nuclear import as monomers (Fig. 1A).
However, both tagged forms of the PB1-PA dimer showed similarly
fast nuclear dynamics to PB2-GFP that again in both cases, dropped
dramatically on formation of the full 3P complex (Figs. 2B, D, Table 1).
Overall, depending on which GFP-tagged polymerase subunit was
employed, between 2- and 10-fold increases in t1/2 and 3- to 10-fold
reductions in DC were observed on formation of the 3P complex, with
the smallest alterations occurring with a labelled PA subunit. t-test
analysis showed these changes in t1/2 and DC upon full polymeraseFig. 3.Distribution of DC values from individual cells. Histograms of DC values from cells trans
the total for each category. The same data are plotted in (A) and (B) but with a smaller binassembly to be highly signiﬁcant (Table 1). Thus assembly of the full
3P complex results in the appearance of an immobile fraction of the
polymerase and markedly lower overall intranuclear dynamics.
Next, the effect of RNP formation on polymerase nuclear dynamics
was examined. NP binds to both PB1 and PB2 in the absence of vRNA
(Biswas et al., 1998; Medcalf et al., 1999), but its co-expression with
PB1-GFP tagged 3P in the absence of the viral genome did not alter
polymerase recovery rates (Figs. 2A, C). Similarly, when a plasmid
expressing the model NSCAT vRNA segment was additionally
transfected to permit the formation of full RNPs, no signiﬁcant
alteration to polymerase dynamics was seen (Figs. 4A, B). RNP size
depends on segment length (reﬂecting the stoichiometric require-
ment for encapsidating NP at approximately 1 NP:24 nucleotides
[Portela and Digard, 2002]), with predicted molecular weights
ranging from approximately 2 MDa for the NSCAT RNP to over
6 MDa for the two largest viral segments. However, when RNPs were
recreated with either of segments 2 or 7, no signiﬁcant alteration to
polymerase mobility was seen. The small variations that were seen
showed no correlation with RNP size (Fig. 4A), nor were the dynamicsfected with the indicated plasmids are shown. Data are plotted on bin centres as the % of
size in (B) to resolve the spread of 3P DC values.
Fig. 4. Nuclear mobility of viral RNPs and NP. (A, B) 293T cells were transfected with plasmids expressing PB2-GFP alone (P) or in combinations with the other polymerase proteins
(3P), NP and model genome segments as indicated or (C, D) GFP-NP alone, in the context of a WT segment 7 RNP (+3Pwt seg7) or in the context of a replication incompetent
segment 7 RNP (+3Psdd seg7). 24 h post-transfection ﬂuorescent cells were analysed by FRAP and (A, C) recovery kinetics were plotted, for comparison, alongside recovery curves
for PB2-GFP alone and in the heterotrimeric polymerase context. (B, D) The mean DC±SEM for each transfection combination are plotted. Asterisks and brackets indicate the
probability (⁎⁎⁎pb0.001; Student's two-tailed t-test, assuming equal variance) of the compared data being equal.
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the isolated polymerase complex (Fig. 4B and data not shown). Primer
extension analysis of RNA isolated from the transfected cells indicated
successful transcription and replication of the input vRNA molecules
(data not shown), conﬁrming successful reconstitution of RNPs in a
least a subset of the transfected cells. However, no shift in the
distribution of even a minority of the individual cell DC values
between 3P and RNP transfected samples was evident (Fig. 3C). Thus
the formation of active RNPs does not inﬂuence the overall dynamics
of the viral polymerase in this system. However, vRNA and cRNA
undergo differential trafﬁcking in infected cells with the former but
not the latter molecules being exported to the cytoplasm (Shapiro et
al., 1987; Tchatalbachev et al., 2001). The reason why cRNPs are
retained in the nucleus is not known but one hypothesis is that it
results from a high afﬁnity interaction with a static component of the
nucleus. Thus it was possible that the intranuclear dynamics of RNPs
formed around the two polarities of viral genomic RNA might differ.
To test this, we reconstituted transcriptionally inert RNPs (tagged
with PB2-GFP) using the PB1-SDD mutant and plasmids that
expressed either vRNA or cRNA polarity NSCAT molecules to produce
either vRNPs or cRNPs. Primer extension analysis of RNA from the
transfected cells again conﬁrmed expression of the expected species
(Fig. 1C). However, FRAP measurements produced recovery curvesand DC values that were essentially indistinguishable from that of
the 3P polymerase complex, thus not supporting the hypothesis that
segment polarity affects the nuclear dynamics of inﬂuenza RNPs
(Figs. 4A, B).
Since formation of RNP complexes does not affect the nuclear
dynamics of the inﬂuenza polymerase we next investigated the effect
of RNP formation from the perspective of NP. NP is the major protein
component of viral RNPs but is also present as free molecules in
infected cells (Beaton and Krug, 1986; Rees and Dimmock, 1982).
Thus the mobility of GFP-NP in the absence or presence of other RNP
components was examined. In FRAP analysis of cells expressing
recombinant GFP-NP alone, ﬂuorescence recovered very slowly post-
bleach and only to about 30% of initial ﬂuorescence intensity (Fig. 4C).
Therefore, GFP-NP exhibits markedly slower nuclear dynamics than
any individual polymerase subunit or even the full polymerase
complex. However, co-expression of 3P and segment 7, thus allowing
RNPs to form, lead to a pronounced increase in recovery rates, with
recovery to nearly 50% of initial ﬂuorescence intensity and a
signiﬁcant 6-fold increase in the DC (Figs. 4C, D). Examination of
the DC values from individual cells showed that this increase in
average DC reﬂected a relatively small increase in values from the
majority of cells coupled with the appearance of a population of cells
(around 20% of the total) with large increases in DC of 10-fold or
159E.M. Loucaides et al. / Virology 394 (2009) 154–163greater (Fig. 3D). To examine whether these ﬁndings held true in the
context of a transcriptionally inert polymerase, PB1 was replaced with
PB1-SDD leaving the other RNP components unchanged. In this
context, GFP-NP displayed slow average dynamics, similar to when
expressed on its own and signiﬁcantly different to the higher mobility
it adopted in the context of active RNPs (Figs. 4C, D). Examination of
the DC values from individual cells showed that all cells analysed
contained slow-moving NP (Fig. 3D), in contrast to when active RNPs
were reconstituted. The same effects were seen when NSCAT vRNA
was used as the model segment (data not shown). To further probe
the association between NP dynamics and viral RNA synthesis, cells
containing transcriptionally active RNPs were marked by utilising a
vRNA encoding RFP. The majority (though not all) of these cells
harboured highly mobile populations of GFP-NP (Fig. 3D). Thus,
formation of transcriptionally active RNPs affects the intranuclear
dynamics of NP, but unexpectedly, by increasing its mobility.
A role for cellular transcription in nuclear dynamics of the viral
polymerase
Evidence for an interaction between the inﬂuenza polymerase and
cellular Pol II (Engelhardt and Fodor, 2006; Mayer et al., 2007;Fig. 5. Role of cellular transcription in the nuclear dynamics of the viral polymerase. (A) 29
amanitin for 9 h, lysed and analysed by SDS-PAGE and Western blotting with sera speciﬁc fo
with expression vectors for the indicated GFP-tagged viral polymerase proteins (3P complex
Pol II inhibitors as in (A) and ﬂuorescent cells then analysed by FRAP. The fold change in mea
plotted. A Student's two-tailed t-test, assuming equal variance, was used to compare DCs o
describing the probability of the compared data being equal. (C) 293T cells were transfecte
complex tagged with PB1-TAP) and 42 h later cell extracts fractionated by IgG sepharose chr
tagged subunits indicated by black spots, (middle panel) western blotting for PB2 or (lo
experiments was quantiﬁed by densitometry and plotted as themean±SEM relative toWT 3
3P are plotted. The 2P value is from PB1-GFP+PA.Rameix-Welti et al., 2009) as well as the dependence of viral gene
expression on functionally and spatially interlinked cellular tran-
scription and mRNA processing machinery (Amorim et al., 2007;
Braam et al., 1983) suggest the hypothesis that the cellular
transcriptosome inﬂuences the nuclear dynamics of the viral
polymerase. To test this, cells transfected for FRAP analysis were
treatedwith two inhibitors of cellular RNA polymerase II: actinomycin
D (ActD) and α-amanitin. To conﬁrm activity of the drug treatments,
cell lysates were analysed by SDS-PAGE and western blotting using
sera to various phosphorylated forms of the C-terminal repeat domain
(CTD) of the large subunit of Pol II. As expected (Casse et al., 1999),
ActD treatment increased levels of serine 2- and serine 5–phosphor-
ylated Pol II while concomitantly, levels of unmodiﬁed serine 2
decreased (Fig. 5A). Also as expected (Casse et al., 1999; Nguyen et al.,
1996), α-amanitin treatment drastically reduced detection of all
forms of Pol II with only low levels of serine 2-phosphorylated RNA
polymerase II detectable in cells treated with the drug (Fig. 5A). When
drug-treated cells were examined by FRAP, neither ActD nor α-
amanitin treatment signiﬁcantly altered the nuclear mobility of GFP
(Fig. 5B; data plotted as fold change in DC in response to the drug
treatment), suggesting that disruption of cellular transcription did not
modify the nuclear environment sufﬁciently to affect the dynamics of3T cells were mock-treated (−), treated with 5 μg/ml ActD for 1 h or with 5 μg/ml α-
r modiﬁed forms of the CTD of RNA Pol II as indicated. (B) 293T cells were transfected
tagged with PB2-GFP) or GFP, 24 h post transfection treated or mock treated with RNA
n DCs of the drug-treated samples relative to the corresponding untreated samples are
f drug-treated and untreated samples and returned p-values (⁎⁎pb0.01, ⁎⁎⁎pb0.001)
d with expression vectors for the indicated TAP-tagged viral polymerase proteins (3P
omatography followed by SDS-PAGE and (top panel) silver staining; migration of TAP-
wer panel) serine 5 phosphorylated Pol II. (D) Bound Pol II from three independent
P (100%). (E) The fold change inmean DC values of the indicated samples relative toWT
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underwent a highly signiﬁcant 5-fold reduction in mobility when cells
were treated with ActD. α-Amanitin, on the other hand, signiﬁcantly
increased mobility of the 3P complex with a 1.6-fold increase in mean
DC (Fig. 5B). This supports the hypothesis that cellular Pol II affects the
intranuclear dynamics of the viral polymerase. Previous work has
shown that a stable interaction between the Pol II CTD and viral
polymerase requires all three viral P proteins to be present
(Engelhardt et al., 2005). Therefore, we tested whether the effect of
inhibiting cellular transcription was speciﬁc to 3P dynamics. Unex-
pectedly, the mobility of PB2-GFP and the GFP-tagged PA-PB1 dimer
was signiﬁcantly reduced 2- to 5-fold by both ActD and α-amanitin
treatment (Fig. 5B). Thus, inhibition of the cellular transcriptosome by
ActD DNA intercalation decreased mobility of all viral polymerase
components tested, while degradation of Pol II due to α-amanitin
treatment accelerated the dynamics of only the full viral polymerase;
in contrast subassemblies of the P complexwere rendered less mobile.
In addition to protein–protein contacts between the viral and
cellular polymerases, there is also the possibility of protein–RNA
bridges, the most obvious of which is via the mRNA cap-binding
activity of PB2 (Elton et al., 2006). To test the contribution this
interaction makes to the intranuclear dynamics of the viral polymer-
ase, we reconstituted the 3P complex with either of two PB2 proteins
containing mutations (F363A or F404A) known to block cap-binding
activity (Fechter et al., 2003; Guilligay et al., 2008). Surprisingly, these
two mutants behaved differently in the FRAP assay. A polymerase
complex incorporating the PB2-F404A mutant behaved similarly to
the WT trimer (Figs. 2B, D). In contrast, co-transfection of PB2-F363A
caused only a slight reduction in the dynamics of the PB1-GFP:PA
dimer (Figs. 2B, D, numerical values given in Table 1). The simplest
explanation for the differing phenotypes of the two cap-binding
mutants was that the F363A mutation affected the folding of the
protein such that it no longer formed a stable complex with PB1 and
PA. Therefore, to test 3P complex formation by the mutant PB2
polypeptides, cells were transfected with combinations of plasmids
encoding tandem afﬁnity puriﬁcation (TAP) sequence-tagged variants
of a single P protein in the presence or absence of the untagged
partners. TAP-tagged and interacting proteins were then partially
puriﬁed by IgG sepharose afﬁnity chromatography (Fodor and Smith,
2004). Individually expressed TAP-tagged PA expressed well, but as
before (Deng et al., 2005), PB1-TAP and PB2-TAP alone were
recovered in relatively low amounts (Fig. 5C top panel, lanes 4–6).
Comparison with material obtained from untransfected cells showed
recovery of some background cellular proteins, including hsp90 (lane
7). However, samples puriﬁed from triply-transfected cells showed
abundant quantities of all three P proteins, whether the complex was
reconstituted with WT PB2 or either cap-binding mutant (lanes 1–3).
Because PB2 and PA nearly co-migrate, levels of co-puriﬁed PB2 were
further examined by western blotting. This conﬁrmed that all three P
protein complexes contained equivalent amounts of PB2 (Fig. 5C,
middle panel). Therefore, as both PB2 mutants are known to be
defective in cap-binding (Fechter et al., 2003; Guilligay et al., 2008)
yet form similarly stable 3P complexes, we sought another explana-
tion for their altered intranuclear dynamics. In light of the identiﬁed
interaction between the inﬂuenza and cellular RNA Pol II complexes
(Engelhardt et al., 2005; Mayer et al., 2007; Rameix-Welti et al., 2009)
and the effect transcriptional poisons had on 3P dynamics (Fig. 5B),
we tested if the PB2 mutations affected Pol II-binding by immuno-
blotting the TAP-puriﬁed inﬂuenza polymerase samples for co-
puriﬁed RNA Pol II. As before (Engelhardt et al., 2005), only trace
amounts of serine 5-phosphorylated Pol II were detectable in samples
puriﬁed frommock transfected cells, whereas abundant quantities co-
puriﬁed with the WT inﬂuenza polymerase (Fig. 5C lower panel,
compare lanes 1 and 7). Similar amounts of Pol II co-puriﬁedwith a 3P
complex containing the PB2-F404A mutant but much reduced
quantities associated with the trimer incorporating the F363A mutant(compare lanes 1, 2 and 3). When replicate experiments were
quantiﬁed, binding activities of the WT and F404A mutants were
equivalent but the F363A-containing complex associated with less
than one-ﬁfth the normal amount of Pol II (Fig. 5D). Thus the F404A
mutation in PB2 which severely reduces cap-binding activity (Fechter
et al., 2003; Guilligay et al., 2008) but does not affect Pol II binding
displays normal intranuclear dynamics while mutant F363A with
deﬁcits in both cap- and pol II-binding activities shows much faster
dynamics (Fig. 4D). This suggests that the interaction between PB2
and mRNA cap-structures is not a major determinant of polymerase
mobility but provides further evidence for the importance of
interactions with cellular Pol II. Furthermore, appreciable quantities
of Pol II bound to PB2-TAP alone, while PB1-TAP also showed activity
slightly above background (Fig. 4C, lanes 4 and 5, quantiﬁcation in Fig.
5D). This contrasts with previous work in which only the 3P complex
was able to detectably bind to the isolated Pol II CTD (Engelhardt et al.,
2005) but is consistent with the altered FRAPmobility of PB2-GFP and
GFP-tagged PB1-PA dimers after treatment with transcriptional
inhibitors (Fig. 4B). Overall, this suggests that the inﬂuenza RNA
polymerase maymake additional contacts with other subunits and/or
domains of the intact RNA Pol II.
Discussion
We have established a FRAP system that has yielded insights into
the nuclear dynamics of inﬂuenza virus RNPs in an authentic live-cell
environment. To our knowledge, no such system has previously been
described. Although it employs subsets of the normal viral genes
expressed from plasmids, RNPs reconstituted with the tagged
subunits were transcriptionally active (Figs. 1B, D) and thus their
behaviour is likely to be a fair reﬂection of the behavior of authentic
RNP components. We show that in a mammalian cell, RNP assembly
state inﬂuences the mobility of both NP and the viral polymerase. The
full 3P complex displays markedly slower mobility than single
polymerase subunits or dimer combinations, while NP mobility
signiﬁcantly increases in response to active RNP formation. We also
ﬁnd that cellular RNA Pol II function is an important determinant of
the dynamics of the viral polymerase.
The assembly state of the viral heterotrimeric polymerase strongly
inﬂuences its nuclear dynamics in mammalian cells with the full
trimer showing markedly reduced mobility compared to individual
subunits or dimers. The relatively fast intranuclear diffusion of PB2 and
PB1-PA is compatible with current data indicating the two sub-
assemblies undergo separate nuclear import (Deng et al., 2005; Fodor
and Smith, 2004; Naito et al., 2007); slow intranuclear dynamics of the
sub-complexesmight otherwise act as a kinetic barrier to formation of
the full 3P polymerase complex. It is alsoworth considering reasons for
the marked decrease in diffusion rate of the 3P complex compared to
its individual components. One possibility is an increase in size; in
simple terms, from ~85 kDa (any of the monomers) to ~170 kDa
(dimer) to ~250 kDa (trimer). However, according to standard
diffusion theory a mere three-fold increase in size of a soluble,
globular protein complex cannot account for such marked reduced
mobility (Lippincott-Schwartz et al., 2001). In addition, evidence
suggests that at least some of the PB1-PA and PB2molecules will be in
complex with cellular proteins that are lost on formation of the viral
heterotrimer (Deng et al., 2005; Fodor and Smith, 2004; Naito et al.,
2007), further reducing themass differential of the various complexes.
While recombinant viral polymerase has been shown to be globular in
appearance both in its soluble and RNP-associated form (Area et al.,
2004; Torreira et al., 2007) it remains to be clariﬁed whether, and to
what extent, the inﬂuenza polymerase multimerizes. Sedimentation
and co-precipitation analyses have provided evidence both for (Digard
et al., 1989; Jorba et al., 2008) and against (Honda et al., 1990)
polymerase aggregates (although the latter study examined virion-
derived polymerase, which may be a special case). It is also worth
161E.M. Loucaides et al. / Virology 394 (2009) 154–163noting that the EM image analysis method used to visualise the
polymerase (Area et al., 2004; Torreira et al., 2007) is biased towards
picking similar structures and would therefore ﬁlter out heteroge-
neous aggregates. Thus while an increase in complex size seems an
unlikely explanation for the slow mobility of the full polymerase
complex, it will nevertheless be worthwhile to clarify the extent of
polymerase aggregation in the FRAP setting. Reduced recovery rates of
photobleached polymerase trimers correlated with a substantial
increase in an apparently immobile pool of 3P as the ﬂuorescence
signal never recovered to initial intensity levels. Overall therefore, we
favour the hypothesis that the slow intranuclear mobility of the full
viral polymerase complex results from a speciﬁc interaction between
the trimer and a relatively immobile cellular component(s).
Bearing in mind the substantial increase in size from a polymerase
trimer to a full RNP complex, it was surprising that no effect of RNP
formation on polymerase dynamics could be detected. One possibility
is that only a relatively small number of transfected cells successfully
reconstituted active RNPs. However, this is inconsistent with the
increase in GFP-NP mobility seen after RNP reconstitution, where an
affect of RNP formation on the mobility of the tagged polypeptide was
clearly demonstrable, both on the dynamics of the total population
and at the level of single cells (Figs. 3D, 4C, D). Furthermore, control
experiments examining the efﬁciency of plasmid-directed RNP
formation (by ﬂuorescent detection of the mRNA or protein product
encoded by the vRNA reporter) indicated that between ~10% and 90%
of cells expressing either NP or PA also contained active RNPs,
depending on the reporter vRNA and detection method employed
(data not shown). Nevertheless, no effect of RNP formation was seen
on the mobility of the polymerase complex, whether in aggregate
(Figs. 4A, B) or at the level of individual cells (Fig. 3C). Therefore it is
possible that the polymerase-RNP interaction is highly dynamic and
occurs fast enough to not mask the characteristic mobility of the
polymerase heterotrimer. Recent work showed that the interaction of
the polymerase complex with the 5′ end of vRNA and especially cRNA
is indeed a dynamic process (Dalton et al., 2006). However, in vitro
dissociation of the polymerase from its template was measurable over
periods of minutes rather than the seconds of FRAP experiments, so it
is not clear whether the two cases are necessarily comparable. Thus a
more conservative (but not necessarily exclusive) explanation for the
lack of effect of RNP formation on 3P dynamics is simply that the bulk
of the polymerase is not RNP-associated in this system. This
explanation does however parallel the situation in infected cells,
where a pool of non-RNP associated polymerase complex exists
(Akkina et al., 1987; Detjen et al., 1987).
In contrast to the behaviour of the polymerase, the nuclear
mobility of NP, the major protein component of RNPs, was strongly
inﬂuenced by RNP assembly state. Recombinant GFP-NP dynamics
were very slow in the absence of other viral proteins, but were
signiﬁcantly faster in the presence of the other RNP components, as
long as they were transcriptionally competent. The failure to increase
NP mobility when transcriptionally inert RNPs were reconstituted
could perhaps be attributed to lower levels of model genome
segments available for NP to interact with, in the absence of
ampliﬁcation of input RNA segments by the polymerase. However,
primer extension analysis detected signiﬁcant levels of c- and vRNA
transcribed from the input plasmids that were not drastically
increased upon WT RNP formation (Fig. 1C). Thus NP is more mobile
when associated with active RNPs than when co-expressed with the
components of replication incompetent RNPs. One possible explana-
tion for this is that the presence of active viral RNPs alters the nuclear
environment in such a way as to alter the dynamics of GFP-NP
monomers. However, we prefer the hypothesis that active transcrip-
tion of RNPs displaces NP bound to the template RNA. Thismechanism
could provide a solution to the problem of steric hindrance that must
otherwise be faced by a polymerase that remains bound to the 5′-end
of vRNA as well as the internal region being copied during mRNAtranscription (Elton et al., 2006; Pritlove et al., 1998). A complete
release of NP monomers from the RNP structure during transcription
contrasts with a model proposed for transcription of non-segmented
negative strand viruses which suggests that the transcribing poly-
merase gains access to the encapsidated template due to a
conformational change in the N protein that locally opens the
structure without disrupting the polymeric N protein backbone of
the RNP (Albertini et al., 2008). Nevertheless, orthomyxovirus RNPs
differ fundamentally from non-segmented virus RNPs in other aspects
of their structure (Klumpp et al., 1997; Pons et al., 1969) so such a
difference is not implausible. If transcription does displace NP from
the RNP, thereby causing an overall increase in the mobility of the
protein pool, recruitment of the soluble protein to the structure(s)
responsible for the very slow dynamics of the non-RNP form must be
relatively slow. An NP mutant (R416A) with a primary defect in
oligomerisation (Elton et al., 1999a; Elton et al., 1999b; Ye et al., 2006)
displayedmuch faster nuclear dynamics (data not shown), suggesting
that the ability to self-associate may be key to the low nuclear
mobility of GFP-NP. While this might thus be a size effect alone, it is
also possible that multimerisation is essential for a high avidity
interaction of NP with an insoluble nuclear component. For example
NP is known to interact with chromatin components (Bukrinskaya et
al., 1979; Garcia-Robles et al., 2005).
Use of drugs that inhibit cellular transcription conﬁrmed that the
cellular Pol II transcriptosome inﬂuences the nuclear dynamics of the
viral polymerase, as did the correlation between the abnormally fast
diffusion of a 3P complex containing the PB2-F363A mutant with a
defect in Pol II-binding. However, Pol II cannot be the sole
determinant of viral polymerase mobility because although its
removal through α-amanitin treatment increased the DC of the
inﬂuenza polymerase, it was not to the level of single or dimeric
polymerase polypeptides, or even to that of the PB2-F363A mutant
(Fig. 4E), all of which retain some ability to interact with Pol II (Fig.
4D). In similar vein, we have also considered the hypothesis that the
sharp drop in DC seen on assembly of the full heterotrimeric inﬂuenza
polymerase results from its interaction with RNA Pol II, as initial work
found that only the 3P complex bound to the CTD of Pol II stably
enough to be detected by biochemical means (Engelhardt et al., 2005).
However, treatment with ActD andα-amanitin altered themobility of
not only the 3P complex but also PB2-GFP alone and the PB1-PA dimer
(Fig. 4B). Moreover, when binding of inﬂuenza P proteins to intact
RNA Pol II (as opposed to the isolated CTD; (Engelhardt et al., 2005))
was examined, a clear interaction with isolated PB2 was seen, as well
as possibly weak binding by PB1 (Figs. 4C, D). The difference in
expression levels between individually and co-expressed PB2 (and
PB1) makes it difﬁcult to compare the relative binding strengths of
single and trimeric P proteins, but it seems likely that PB2 contributes
signiﬁcantly to the interaction with Pol II, possibly via the cap-binding
domain. Overall, the FRAP analyses of polymerase mobility are likely
to report a summation of multiple interactions, some too weak to be
easily detected by biochemical means. We suspect that the complex
effects of transcriptional poisons on the dynamics of sub-assemblies of
the viral polymerase reﬂects this, as well as potential indirect effects
on the nuclear environment resulting from the inhibition of cellular
mRNA synthesis.
Overall, the live-cell imaging and FRAP system described here has
proven useful to further understand the intracellular dynamics of the
four viral polypeptides minimally required for transcription and
replication of the virus genome and their interactions with the cellular
transcription machinery. Further work will explore its potential to
inform on the interactions of other viral polypeptides that while not
essential for viral RNA synthesis, nevertheless interact with RNPs
(Bullido et al., 2001; Kuo and Krug, 2009; Marion et al., 1997; Mazur et
al., 2008; Robb et al., 2009; Wise et al., 2009) as well as with
interactions with cellular proteins potentially involved in determining
inﬂuenza virus host range (Naffakh et al., 2008).
162 E.M. Loucaides et al. / Virology 394 (2009) 154–163Materials and methods
Cell culture, virus, plasmids and drugs
Human embryonic kidney 293T cells were cultured and trans-
fected with plasmids as described (Amorim et al., 2007). Plasmids
expressing untagged A/PR/8/34 (PR8) and GFP-tagged A/WSN/33
(WSN) PB2, -PB1, -PA and PR8 GFP-NP proteins as well as pPol-I(+)
NS.CAT and pPol-I(−)NS.CAT have previously been described (Fodor
and Smith, 2004; Mullin et al., 2004). Plasmids encoding the WSN
PB2-F363A and –F404A mutants are described in (Fechter et al.,
2003). Plasmid pcDNA-PB1-SDD was constructed by site-directed
mutagenesis using the primers 5′-TCAATCCTCTGCAGCTTTTGCTCTGA
and 5′-TCAGAGCAAAAGCTGCAGAGGATTGA generating a double
mutation in the conserved SDD motif of the polymerase active site
of PB1 (PB1-D445A/D446A). Plasmids pPolI-seg1 and pPolI-seg7 that
express PR8 vRNA segments 1 and 7 respectively were the generous
gift of Professor Ron Fouchier (de Wit et al., 2004). pPOLI-DsRed was
generated by replacing the chloramphenicol acetyltransferase (CAT)
open reading frame (ORF) of the pPOLI-CAT-RT plasmid (Pleschka et
al., 1996) with red ﬂuorescent protein (dsRed) ORF ampliﬁed by PCR
using pDsRed1-N1 (Clontech) as template. Actinomycin D (Sigma),
which blocks transcription through intercalation into the DNA
template (Casse et al., 1999), was solubilised in methanol to a stock
of 5 mg/ml and used at 5 μg/ml. 293T cells were treated with ActD for
1 h or with α-amanitin for 9 h Amanitin binds the large subunit of Pol
II, prevents NTP incorporation and (after prolonged treatment),
triggers its degradation (Nguyen et al., 1996)).
Protein analyses
Anti-PolII CTD monoclonal antibodies 8WG16 (preferentially
recognising hypophosphorylated CTD), H5 (phosphoserine 2) H14
(anti-phosphoserine 5) were obtained from Covance Ltd. Rabbit
polyclonal sera to PA (V35-F3), PB2 (2N580 or His1-180) and NP
(A2195) have been previously described (Carrasco et al., 2004; Digard
et al., 1989; Engelhardt et al., 2005; Noton et al., 2007). Anti-PB1
monoclonal antibody 44–69was the kind gift of DrMark Krystal while
amonoclonal antibody against GFPwas obtained from BD Biosciences.
For Western blots, cell lysates were separated by 10% SDS-PAGE
and transferred to nitrocellulose. Blots were probed with primary
followed by secondary antibodies conjugated to horseradish perox-
idase (DAKO) or IRDye800 (LiCor Biosciences) and developed by
chemiluminescence (ECL reagent; Amersham Biosciences) or ﬂuores-
cence on an Odyssey infrared imaging platform. TAP-tag puriﬁcation
of viral polymerase subunits was carried out as previously described
(Engelhardt et al., 2005; Fodor and Smith, 2004).
Inﬂuenza virus gene expression assay and RNA primer extension analysis
1×106 cells per 35 mm well in 1 ml complete medium were
transfected in suspension with plasmid DNA using cationic liposomes
(Lipofectin; Gibco-BRL). 250 ng of any PA, PB1, PB2 and NP expression
plasmid and 100 ng of pPol-I(+)NS.CAT were transfected. Following
incubation at 37 °C for 2 or 3 days, CAT accumulation was quantiﬁed
by ELISA (Roche Diagnostics). For examination of viral RNA
accumulation, total cellular RNA was extracted and primer extension
analysis was carried out as described previously (Mullin et al., 2004).
FRAP microscopy and data analysis
Cells on 42 mm coverslips were transferred to live-cell chambers
and maintained at 37 °C in CO2 independent medium (Gibco). Images
were captured on a Zeiss LSM 510 confocal microscope using a 63X
objective and a digital zoom factor of 5. GFP was excited using the
488 nm laser line of a 30-mW Ar laser running at 6.1A and 1% output.Photobleaching was performed on a 1.4 μm2 bleach window at 100%
laser output. Five pre-bleach and 70 post-bleach images were
collected at 0.39-s intervals. Fluorescence intensities of regions of
interest were obtained using the LSM510 software. Background
ﬂuorescence and acquisition bleaching were adjusted for and
ﬂuorescence intensity was normalised using the following equation:
(F(t)-BF) /(R(t)- BF) x NF where F(t) is the observed ﬂuorescence at
time t, BF is the mean measured background ﬂuorescence, R(t) is the
ﬁtted ﬂuorescence in the reference window at time t and NF is a
normalisation factor equal to the average of the recorded values of (F
(t)-BF)/(R(t)- BF) before bleaching. The average ﬂuorescence recov-
ery curves generated from multiple individual cells from a minimum
of two independent transfections are presented. Times to half
recovery (t1/2) and diffusion coefﬁcient (DC) values were determined
(from recovery curves from individual cells) by adapted classical FRAP
analysis as described (Axelrod et al., 1976). For statistical analysis of
averaged DC and t1/2 data, two-tailed Student's t-tests assuming
equal variance were carried out. It should be borne in mind that this
method of FRAP analysis reports the average behaviour of the
ﬂuorescently tagged protein pool in a cell rather than examining the
movement of individual molecules.
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